Literature DB >> 20029955

Tumor flare reactions and response to lenalidomide in patients with refractory classic Hodgkin lymphoma.

Gaetano Corazzelli, Rosaria De Filippi, Gaetana Capobianco, Ferdinando Frigeri, Vincenzo De Rosa, Giancarla Iaccarino, Filippo Russo, Manuela Arcamone, Cristina Becchimanzi, Stefania Crisci, Gianpaolo Marcacci, Barbara Amoroso, Secondo Lastoria, Antonio Pinto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20029955     DOI： 10.1002/ajh.21571

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  8 in total

Review 1.  Gemcitabine and other new cytotoxic drugs: will any find their way into primary therapy?

Authors:  David W Dougherty; Jonathan W Friedberg
Journal:  Curr Hematol Malig Rep       Date:  2010-07       Impact factor: 3.952

2.  Biological effects and clinical significance of lenalidomide-induced tumour flare reaction in patients with chronic lymphocytic leukaemia: in vivo evidence of immune activation and antitumour response.

Authors:  Asher A Chanan-Khan; Kasyapa Chitta; Noreen Ersing; Aneel Paulus; Aisha Masood; Taimur Sher; Abhisek Swaika; Paul K Wallace; Terry L Mashtare; Greg Wilding; Kelvin Lee; Myron S Czuczman; Ivan Borrello; Naveen Bangia
Journal:  Br J Haematol       Date:  2011-10-20       Impact factor: 6.998

Review 3.  Rethinking clinical response and outcome assessment in a biologic age.

Authors:  Bruce D Cheson
Journal:  Curr Oncol Rep       Date:  2015-06       Impact factor: 5.075

4.  Tumor flare reaction in a patient with mantle cell lymphoma.

Authors:  Yusuf Kayar; Nuket Bayram Kayar
Journal:  Blood Res       Date:  2014-12-23

Review 5.  Role of immune escape mechanisms in Hodgkin's lymphoma development and progression: a whole new world with therapeutic implications.

Authors:  Luis de la Cruz-Merino; Marylène Lejeune; Esteban Nogales Fernández; Fernando Henao Carrasco; Ana Grueso López; Ana Illescas Vacas; Mariano Provencio Pulla; Cristina Callau; Tomás Álvaro
Journal:  Clin Dev Immunol       Date:  2012-08-15

6.  Pathobiology of hodgkin lymphoma.

Authors:  Pier Paolo Piccaluga; Claudio Agostinelli; Anna Gazzola; Claudio Tripodo; Francesco Bacci; Elena Sabattini; Maria Teresa Sista; Claudia Mannu; Maria Rosaria Sapienza; Maura Rossi; Maria Antonella Laginestra; Carlo A Sagramoso-Sacchetti; Simona Righi; Stefano A Pileri
Journal:  Adv Hematol       Date:  2010-12-22

7.  Tumour flare reaction in cancer treatments: a comprehensive literature review.

Authors:  Amina Taleb B
Journal:  Anticancer Drugs       Date:  2019-10       Impact factor: 2.248

8.  Tumor Flare Reaction in a Classic Hodgkin Lymphoma Patient Treated With Brentuximab Vedotin and Tislelizumab: A Case Report.

Authors:  Chunting Zhu; Yi Zhao; Fang Yu; Weijia Huang; Wenjun Wu; Jingsong He; Zhen Cai; Donghua He
Journal:  Front Immunol       Date:  2022-01-14       Impact factor: 7.561
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.